Telos Biotech is a biotechnology startup that develops technologies to enhance the manufacturing of cell therapies. The company, launched by Cambrian Bio in 2022, focuses on addressing telomere shortening during cell expansion to improve the function, longevity, and robustness of therapeutic cells used to treat cancer and age-related diseases.
Company Values
The company's key differentiator is its selective telomere lengthening approach, which specifically targets and extends only the shortest telomeres. This method is designed to be safer and more effective than traditional methods, resulting in more robust and durable engineered cells.